Prevencio, Inc., founded with the mission to revolutionize cardiovascular health, is a US-based life science company focused on developing advanced diagnostic and prognostic products. The company leverages AI-powered blood tests to provide early detection and prevention of cardiovascular diseases, aiming to reduce unnecessary procedures and their associated side effects. Prevencio's core market includes emergency rooms, cardiology clinics, and clinical laboratories across the United States.
Notable individuals affiliated with Prevencio include experts in cardiology and biotechnology, contributing to the company's innovative approach. Prevencio has garnered attention for its cutting-edge technology and has been featured in prominent medical publications. Its key achievements include the development of personalized blood tests that significantly enhance early detection of heart disease and stroke, thereby making a substantial impact on patient outcomes and healthcare efficiency.
